Oura is going public, but these smart ring companies are coming for its crown

Oura’s impending IPO marks a pivotal moment for the smart ring category, which has long been a one-brand story. For years, Oura enjoyed near-monopoly status, leveraging its sleep-tracking pedigree and celebrity endorsements to become the default choice for quantified-self enthusiasts. But the market has shifted: the entry of Samsung’s Galaxy Ring signaled that big tech sees smart rings as the next frontier in on-body computing, while startups like Ultrahuman and RingConn have undercut Oura on price and packed in features like AFib detection and continuous glucose monitoring. The competitive pressure is no longer hypothetical—it’s eroding Oura’s growth narrative just as it seeks public capital. What’s interesting is not just the number of rivals, but the diversity of their approaches. Some are chasing the “ecosystem play,” integrating tightly with smartphones and smartwatches; others are targeting specific health niches, like metabolic health or sports recovery. Oura, meanwhile, has doubled down on its subscription model and clinical partnerships, betting that deep data insights and regulatory clearances will justify its premium price. That strategy has worked so far, but the IPO will force it to face a hard question: can a company that relies on a $5.99/month subscription for advanced features sustain growth when competitors offer similar hardware for less and include the app for free? The timing is also tricky. Wearables are facing a broader slowdown in consumer spending, and investors are increasingly skeptical of hardware companies with recurring-revenue ambitions unless they can demonstrate clear path to profitability. Oura’s financials—reportedly strong, with over a million units sold in 2024—will need to show not just growth but defensibility. The smart ring market is still small compared to smartwatches, but its potential is huge, and that’s why so many are piling in. Oura’s IPO will be a referendum on whether first-mover advantage can survive a crowded field, or whether it will go the way of other pioneers like Fitbit, which was acquired after losing its edge. For the tech press, this is a classic David-versus-Goliath narrative with a twist: Oura is the Goliath, but it’s also the underdog in terms of resources against the likes of Samsung. The real story is the commoditization of health sensors—how a device that once felt revolutionary is becoming a standard feature in wearables. Oura’s challenge is to convince investors that its proprietary algorithms and brand cachet are moats, not just marketing. If it succeeds, the IPO could validate the entire category; if it stumbles, it will be a cautionary tale about the speed of disruption in consumer hardware. Either way, the next 12 months will define the smart ring landscape.